New chairman of the board for Varian

Kathy Mahdoubi | | Health Imaging | Molecular Imaging

Varian Medical Systems out of Palo Alto, Calif., elected Andrew Eckert, 52, as head of the board of directors, the manufacturer of radiation oncology technology announced Feb. 20. 

The new chairman is replacing 74-year-old Richard M. Levy, who has been leading the board since 2002. Eckert has been a member of Varian’s board of directors since 2004 and is currently CEO of CRC Health Corporation. He is also former CEO of SumTotal Systems, ADAC Laboratories and Eclipsys Corporation.  

"Under Dick's guidance, the company established itself as the world's leading innovator and supplier of products for treating cancer with radiation oncology,” remarked Eckert in a release. “Furthermore, the company has capitalized on components technology developed under Dick's leadership to advance the science and benefits of X-ray imaging."

Varian’s technology centers on detector technology and systems used in radiotherapy, radiosurgery and brachytherapy. Eckert’s leadership of the board of directors took effect Feb. 20 upon conclusion of the company’s most recent stockholder’s meeting.

Kathy Mahdoubi

Related Content

Repurposed radiotracer lights up treatment-resistant tumors 'like a Christmas tree'
Researchers receive grant worth millions to develop portable PET scanner
Why is the US still dependent on foreign medical isotope production?
Downed high-flux reactor could restart sooner than anticipated
Some nuc med departments are already feeling the strain of the isotope shortage
NorthStar opens facility to assist with development and distribution of vital radioisotopes

Around the web

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease. 

Cardiovascular Business
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

Cardiovascular Business
New AI program delivers rapid, accurate echo video assessments

The new technology shows early potential to make a significant impact on imaging workflows and patient care.